AIM ImmunoTech Inc. (AIM)
$0.18+0.00%Close
SELLCRISIS · day 29
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $612,637
- Beta
- 1.27
- P/E (TTM)
- -0.05
- Short % float
- 50.66%
- Days to cover
- 1.0
- SI change
- -49.1%
- 1W
- +0.00%
- 1M
- -21.74%
- vs SPY 1W
- -1.16%
- vs SPY 1M
- -24.73%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
ANALYST & RATINGS
LOADING…Loading analyst data…
Company news
FAQ
- What is LOPJLB’s current signal on AIM?
- LOPJLB’s latest quantitative signal on AIM ImmunoTech Inc. (AIM) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is AIM in?
- AIM ImmunoTech Inc. (AIM) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does AIM ImmunoTech Inc. (AIM) do?
- AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, a…